Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
— Technology currently being evaluated for the treatment of ovarian cancer in Phase 1 clinical trial —
SAN JOSE, Calif., July 11, 2023 /PRNewswire/ Anixa Biosciences, Inc. , a.
/PRNewswire/ Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in.
/PRNewswire/ Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa") a biotechnology company focused on the treatment and prevention of cancer and infectious.